These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34342378)

  • 61. Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients-a nationwide register-based open cohort study.
    Bondo L; Eiken P; Abrahamsen B
    Osteoporos Int; 2013 Jan; 24(1):245-52. PubMed ID: 22638712
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.
    Adler RA; El-Hajj Fuleihan G; Bauer DC; Camacho PM; Clarke BL; Clines GA; Compston JE; Drake MT; Edwards BJ; Favus MJ; Greenspan SL; McKinney R; Pignolo RJ; Sellmeyer DE
    J Bone Miner Res; 2016 Jan; 31(1):16-35. PubMed ID: 26350171
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Osteoporosis treatment rate following hip fracture in a community hospital.
    Khan AA; AbuAlrob H; Tariq F; Tauqir M; Zalzal P; M'Hiri I; Khan M; Ginty M; Weening B
    Arch Osteoporos; 2021 Jan; 16(1):8. PubMed ID: 33409668
    [TBL] [Abstract][Full Text] [Related]  

  • 64. FRAX provides robust fracture prediction regardless of socioeconomic status.
    Brennan SL; Leslie WD; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
    Osteoporos Int; 2014 Jan; 25(1):61-9. PubMed ID: 24190425
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hip fracture risk in patients with alcoholic cirrhosis: A population-based study using English and Danish data.
    Otete H; Deleuran T; Fleming KM; Card T; Aithal GP; Jepsen P; West J
    J Hepatol; 2018 Sep; 69(3):697-704. PubMed ID: 29673756
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Osteoporosis prevalence and characteristics of treated and untreated nursing home residents with osteoporosis.
    Zarowitz BJ; Cheng LI; Allen C; O'Shea T; Stolshek B
    J Am Med Dir Assoc; 2015 Apr; 16(4):341-8. PubMed ID: 25726417
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry.
    Leslie WD; Majumdar SR; Morin SN; Lix LM; Schousboe JT; Ensrud KE; Johansson H; McCloskey EV; Kanis JA
    Osteoporos Int; 2018 Mar; 29(3):759-767. PubMed ID: 29404625
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fracture risk prediction using FRAX®: a 10-year follow-up survey of the Japanese Population-Based Osteoporosis (JPOS) Cohort Study.
    Tamaki J; Iki M; Kadowaki E; Sato Y; Kajita E; Kagamimori S; Kagawa Y; Yoneshima H
    Osteoporos Int; 2011 Dec; 22(12):3037-45. PubMed ID: 21279504
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010.
    Klop C; Gibson-Smith D; Elders PJ; Welsing PM; Leufkens HG; Harvey NC; Bijlsma JW; van Staa TP; de Vries F
    Osteoporos Int; 2015 Jul; 26(7):1919-28. PubMed ID: 25963232
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fracture Risk Assessment: From Population to Individual.
    Nguyen TV; Eisman JA
    J Clin Densitom; 2017; 20(3):368-378. PubMed ID: 28729045
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fragility Fractures in Postmenopausal Women: Development of 5-Year Prediction Models Using the FRISBEE Study.
    Baleanu F; Moreau M; Charles A; Iconaru L; Karmali R; Surquin M; Benoit F; Mugisha A; Paesmans M; Rubinstein M; Rozenberg S; Bergmann P; Body JJ
    J Clin Endocrinol Metab; 2022 May; 107(6):e2438-e2448. PubMed ID: 35176768
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prediction of absolute risk of fragility fracture at 10 years in a Spanish population: validation of the WHO FRAX ™ tool in Spain.
    Azagra R; Roca G; Encabo G; Prieto D; Aguyé A; Zwart M; Güell S; Puchol N; Gene E; Casado E; Sancho P; Solà S; Torán P; Iglesias M; Sabaté V; López-Expósito F; Ortiz S; Fernandez Y; Diez-Perez A
    BMC Musculoskelet Disord; 2011 Jan; 12():30. PubMed ID: 21272372
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Does osteoporosis therapy invalidate FRAX for fracture prediction?
    Leslie WD; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA;
    J Bone Miner Res; 2012 Jun; 27(6):1243-51. PubMed ID: 22392538
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.
    Burge RT; Disch DP; Gelwicks S; Zhang X; Krege JH
    Osteoporos Int; 2017 Mar; 28(3):799-809. PubMed ID: 28028555
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of Stroke History on the Risk of Recurrent Hip Fracture or Major Osteoporotic Fractures among Patients with Incident Hip Fracture: A Nationwide Cohort Study.
    Hjelholt TJ; Johnsen SP; Brynningsen PK; Andersen G; Pedersen AB
    J Bone Miner Res; 2023 Feb; 38(2):278-287. PubMed ID: 36533810
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Orthopedic-Metabolic Collaborative Management for Osteoporotic Hip Fracture.
    Rotman-Pikielny P; Frankel M; Lebanon OT; Yaacobi E; Tamar M; Netzer D; Nabriski D; Nyska M; Brin YS
    Endocr Pract; 2018 Aug; 24(8):718-725. PubMed ID: 30084682
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy and safety of teriparatide in bisphosphonate-pretreated and treatment-naive patients with osteoporosis at high risk of fracture: Post hoc analysis of a prospective observational study.
    Yoshiki F; Nishikawa A; Taketsuna M; Kajimoto K; Enomoto H
    J Orthop Sci; 2017 Mar; 22(2):330-338. PubMed ID: 28038880
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Determinants of change in bone mineral density and fracture risk during bisphosphonate holiday.
    Xu LH; Adams-Huet B; Poindexter JR; Maalouf NM
    Osteoporos Int; 2016 May; 27(5):1701-8. PubMed ID: 26642963
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 3D Finite Element Models Reconstructed From 2D Dual-Energy X-Ray Absorptiometry (DXA) Images Improve Hip Fracture Prediction Compared to Areal BMD in Osteoporotic Fractures in Men (MrOS) Sweden Cohort.
    Grassi L; Väänänen SP; Jehpsson L; Ljunggren Ö; Rosengren BE; Karlsson MK; Isaksson H
    J Bone Miner Res; 2023 Sep; 38(9):1258-1267. PubMed ID: 37417707
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.